Details
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Modal Labs $750M Series DArmadin $255.5M Series BRecent funding activity in US startups, organised by investor and their role in each round.
New companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Modal Labs $750M Series DArmadin $255.5M Series BNew companies 1 · Follow-on 1
Stages: Series B 1, Series C+ 1
Modal Labs $750M Series DArmadin $255.5M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Modal Labs $750M Series DArmadin $255.5M Series BNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Ultra Robotics $50M Series AMecka $60M Series BNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Vesta $30M Series BHomeward $120M Series DNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Persona $10M UndisclosedMelius $20M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Vinci $250M Series BDevoted Health $555M Series GNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Healthleap $30M Series AConway Research Undisclosed First financingNew companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Supabase Undisclosed Funding roundDevoted Health $555M Series G“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.